These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9872204)

  • 21. Inhibition of angiogenesis in vivo by interleukin 12.
    Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
    J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer.
    Yuan A; Yu CJ; Kuo SH; Chen WJ; Lin FY; Luh KT; Yang PC; Lee YC
    J Clin Oncol; 2001 Jan; 19(2):432-41. PubMed ID: 11208836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity correlates with growth of transplantable osteosarcomas in rats treated with cis-diammine dichloroplatinum or the angiogenesis inhibitor AGM-1470.
    Kido A; Tsujiuchi T; Morishita T; Tsutsumi M; Takahama M; Miyauchi Y; Mii Y; Tamai S; Konishi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1074-81. PubMed ID: 9849588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis.
    Stoeltzing O; Liu W; Reinmuth N; Parikh A; Ahmad SA; Jung YD; Fan F; Ellis LM
    Ann Surg Oncol; 2003 Aug; 10(7):722-33. PubMed ID: 12900362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
    Shibusa T; Shijubo N; Abe S
    Clin Cancer Res; 1998 Jun; 4(6):1483-7. PubMed ID: 9626466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New molecular target of cancer therapy--angiogenesis regulator VEGF].
    Toi M; Ueno T; Tominaga T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2202-6. PubMed ID: 9422062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [VEGF121 expression and angioneogenesis in lung cancer].
    Ota Y; Shimizu J; Oda M; Hayashi Y; Kure T; Nagatoshi A; Tabata T; Watanabe Y
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):396-8. PubMed ID: 9235356
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cancer therapy targeting tumor-induced neovascularization].
    Sato K; Kato T
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):295-300. PubMed ID: 7509149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of experimental antiangiogenic therapy.
    Brem H; Folkman J
    J Pediatr Surg; 1993 Mar; 28(3):445-50; discussion 450-1. PubMed ID: 7682259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
    Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.
    Guba M; von Breitenbuch P; Steinbauer M; Koehl G; Flegel S; Hornung M; Bruns CJ; Zuelke C; Farkas S; Anthuber M; Jauch KW; Geissler EK
    Nat Med; 2002 Feb; 8(2):128-35. PubMed ID: 11821896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
    Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
    J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
    [No Abstract]   [Full Text] [Related]  

  • 38. Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers.
    Takahama M; Tsutsumi M; Tsujiuchi T; Kido A; Okajima E; Nezu K; Tojo T; Kushibe K; Kitamura S; Konishi Y
    Jpn J Clin Oncol; 1998 Mar; 28(3):176-81. PubMed ID: 9614439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in the study of the role of vascular endothelial growth factor and its receptor in tumor angiogenesis and its relation with anti-angiogenesis effect].
    Bian X; Shi J
    Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):248-50. PubMed ID: 10072871
    [No Abstract]   [Full Text] [Related]  

  • 40. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
    J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.